Overview Fundamentals API Earnings EOD API Sample Code Pricing

Vigil Neuroscience Inc (VIGL NASDAQ) stock market data APIs

$3.74 0.07(1.9%) as of September 13, 2024
Price chart is built with Anychart

Vigil Neuroscience, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare and common neurodegenerative diseases by restoring the vigilance of microglia, the sentinel immune cells of the brain. Its lead candidate is VGL101(Iluzanebart), a human monoclonal antibody agonist targeting human triggering receptor expressed on myeloid cells 2 and is in a Phase 2 trial in patients with adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP), a rare and fatal neurodegenerative disease. The company is also developing VG-3927, an orally-available small molecule TREM2 agonist to treat common neurodegenerative diseases associated with microglial dysfunction, with an initial focus on Alzheimer's disease in genetically defined subpopulations, which is being evaluated in a Phase 1 clinical trial. It has license agreement with Amgen Inc. to commercially develop, manufacture, use, distribute, and sell therapeutic products containing compounds that bind to TREM2. The company was incorporated in 2020 and is headquartered in Watertown, Massachusetts.

Vigil Neuroscience Inc Financial Data Overview

3.67
3.74
-
3.8
3.665
2.47-9.24
146 M
39 648 K
0
-0.52
1.972
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'VIGL',
Type: 'Common Stock',
Name: 'Vigil Neuroscience Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG00YGBK4Q4',
ISIN: NULL,
CUSIP: NULL,
CIK: '1827087',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2022-01-07',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: NULL,
IsDelisted: false,
}

Vigil Neuroscience Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 0
  • EBITDA -89 622 000
  • Earnings Per Share -2.11
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Vigil Neuroscience Inc Earnings via APIs

  • Latest Release 2024-08-13
  • EPS/Forecast -0.55

Get Vigil Neuroscience Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com